Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
作者信息
Scantlebury V P, Shapiro R, McCauley J, Jordan M, Vivas C, Irish W, Tzakis A, Ellis D, Gilboa N, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh School of Medicine, PA 15213.
出版信息
Transplant Proc. 1995 Feb;27(1):842-3.
Abstract
摘要
相似文献
1
Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
Transplant Proc. 1995 Feb;27(1):842-3.
2
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.曾因溶血尿毒综合征导致肾功能丧失的患者在使用FK 506的情况下进行肾移植。
Transplant Proc. 1991 Dec;23(6):3068-70.
3
FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient.
Transpl Int. 1994 Aug;7(5):382-4. doi: 10.1007/BF00336717.
4
FK 506 in a 14-year-old renal allograft recipient with cyclosporine-related liver nephrotoxicity: 1-year follow-up.
Transplant Proc. 1991 Dec;23(6):3082-4.
5
Outcome of renal transplantation in 34 cases of childhood hemolytic-uremic syndrome and the role of cyclosporine.
Transplant Proc. 1994 Feb;26(1):269-70.
6
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
Transplant Proc. 1998 Jun;30(4):1292-4. doi: 10.1016/s0041-1345(98)00246-2.
7
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.转换为 FK 506（他克莫司）治疗对环孢素耐药的急性移植物抗宿主病或环孢素相关毒性后的临床结局。
Bone Marrow Transplant. 2000 Nov;26(9):985-91. doi: 10.1038/sj.bmt.1702639.
8
The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.
Transplantation. 1995 Jun 27;59(12):1737-9. doi: 10.1097/00007890-199506270-00017.
9
One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion.
Transplant Proc. 2002 Aug;34(5):1935-8. doi: 10.1016/s0041-1345(02)03128-7.
10
Preliminary experience with FK 506 in pediatric renal transplant recipients: a single-center report.
Transplant Proc. 1996 Apr;28(2):993-4.
引用本文的文献
1
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use.依库珠单抗治疗非典型溶血尿毒综合征：限制使用策略。
Pediatr Nephrol. 2019 Nov;34(11):2261-2277. doi: 10.1007/s00467-018-4091-3. Epub 2018 Nov 6.
2
Tacrolimus (FK506)-Associated Renal Pathology.他克莫司（FK506）相关的肾脏病理学。
Adv Anat Pathol. 1997 Jul;4(4):265-276. doi: 10.1097/00125480-199707000-00032.
3
The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.儿童肾移植后溶血尿毒综合征复发的风险
Pediatr Nephrol. 2003 Nov;18(11):1095-101. doi: 10.1007/s00467-003-1289-8. Epub 2003 Sep 17.
4
Drug-induced thrombotic microangiopathy: incidence, prevention and management.药物诱导的血栓性微血管病：发病率、预防与管理
Drug Saf. 2001;24(7):491-501. doi: 10.2165/00002018-200124070-00002.
本文引用的文献
1
Hemolytic-uremic syndrome.
Curr Probl Pediatr. 1993 Jan;23(1):16-33. doi: 10.1016/0045-9380(93)90027-a.
2
Prognostic factors of hemolytic uremic syndrome in renal allografts.
Transplant Proc. 1993 Feb;25(1 Pt 2):1041-2.
3
Renal transplantation in 20 children with hemolytic-uremic syndrome.20例溶血尿毒综合征患儿的肾移植
Clin Nephrol. 1990 Feb;33(2):87-93.
4
Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.溶血尿毒综合征患者移植后的结局：最新情况
Pediatr Nephrol. 1991 Jan;5(1):162-7. doi: 10.1007/BF00852876.
5
Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome.曾因溶血尿毒综合征导致肾功能丧失的患者在使用FK 506的情况下进行肾移植。
Transplant Proc. 1991 Dec;23(6):3068-70.
Zotero 插件